首页> 外文期刊>Journal of critical care >Vasoplegia in septic shock: Do we really fight the right enemy?
【24h】

Vasoplegia in septic shock: Do we really fight the right enemy?

机译:Vasoplegia在脓毒症休克:我们真的对抗正确的敌人吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Vasoplegia is a key factor for the death of patients with septic shock in intensive care unit owing to persistent and irreversible hypotension. Impairment of vascular reactivity has been attributed to a combination of endothelial injury, arginine-vasopressin system dysfunction, release of other vasodilatory inflammatory mediators, and muscle hyperpolarizaton. Nitric oxide induced by a Ca+2 independent isoform of nitric oxide synthase has been suggested to play an important role in sepsis-induced vasoplegia. However, inhibition of nitric oxide synthase only partially restores the endotoxin-induced vascular hyporeactivity. The aim of this review is to discuss in detail the recent suggested alternative mechanisms of vasoplegia and to briefly outline the current therapeutic strategies and the novel therapeutic options based on those mechanisms.
机译:由于持久性和不可逆的低血压,Vasoplegia是一种强化护理单元患者死亡的关键因素。 血管反应性的损害归因于内皮损伤,精氨酸 - 血管素系统功能障碍,释放其他血管抑制炎症介质和肌肉超引发剂。 已经提出了通过一氧化氮合酶的Ca + 2独立同种型诱导的一氧化氮,以在败血症诱导的肠蠕动中发挥重要作用。 然而,抑制一氧化氮合酶仅部分地恢复内毒素诱导的血管性低于性。 本综述的目的是详细讨论近期提出的Vasoplegia的替代机制,并简要概述当前的治疗策略和基于这些机制的新的治疗案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号